FIGURE

Fig. 7

ID
ZDB-FIG-220824-60
Publication
Zhou et al., 2022 - Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing m6A-mediated degradation of STEAP3 mRNA
Other Figures
All Figure Page
Back to All Figure Page
Fig. 7

STEAP3-AS1/STEAP3-mediated Fe2+ inactivates GSK3? to stimulate wnt/?-catenin signaling. A Relative cellular Fe2+ level in DLD-1 and SW480 cells with or without STEAP3-AS1 knockdown. B TOP/FOP flash assay for detecting the transcriptional activity of Wnt/?-catenin signaling in control or STEAP3-AS1 knockdown DLD-1 cells with or without FeSO4 (100 ?M) treatment for 48 h. C After treatment with or without FeSO4 (100 ?M) for 48 h, control or STEAP3-AS1 knockdown DLD-1 and SW480 cells were analyzed to show the subcellular distribution of ?-catenin using nuclear/cytoplasmic fractionation and subsequent WB analysis. (Cyto, cytoplasm; Nuc, nucleus). D Control or STEAP3-AS1 knockdown DLD-1 and SW480 cells were seeded on slides on 24 well-plates overnight and treated as in (C), IF assay was conducted to detect the subcellular distribution of ?-catenin. Scale bar: 10 ?m. (E-F) Control or STEAP3-AS1 knockdown DLD-1 and SW480 cells were seeded on a culture dish overnight and treated as in (C). Immunoprecipitation (IP) and WB analysis were performed to observe the interaction between ?-catenin and GSK3?. G The efficiency of siRNA-mediated GSK3? knockdown was measured by western blotting. H The colony formation of control and STEAP3-AS1 knockdown DLD-1 and SW480 cells treated with or without GSK3? siRNA. I Wound healing assay and relative migration distance of control and STEAP3-AS1-knockdown DLD-1 and SW480 cells treated with or without GSK3? siRNA. Scale bar: 100 ?m. J Control or STEAP3-AS1 knockdown DLD-1 and SW480 cells were treated as in (C). Cell growth was performed by MTT assay over a 3-day period. (sh#1, shSTEAP3-AS1 #1). K Control or STEAP3-AS1 knockdown DLD-1 cells were treated as in (C). Migration and invasion of DLD-1 cells were evaluated by transwell assays. Scale bar: 100 ?m. (sh#1, shSTEAP3-AS1 #1; sh#2, shSTEAP3-AS1 #2). Data are means ± s.d. and are representative of at least 3 independent experiments. (** P < 0.01 and *** P < 0.001)

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Mol. Cancer